🇺🇸 FDA
Patent

US 6270778

Melanoma antigens and their use in diagnostic and therapeutic methods

expired A61KA61K2039/5256A61K2039/53

Quick answer

US patent 6270778 (Melanoma antigens and their use in diagnostic and therapeutic methods) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/5256, A61K2039/53, A61K2239/31, A61K2239/38